Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Telix Pharmaceuticals Limited - American Depositary Shares
(NQ:
TLX
)
11.27
+0.73 (+6.93%)
Streaming Delayed Price
Updated: 3:27 PM EDT, Apr 13, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
324,152
Open
11.03
Bid (Size)
11.26 (400)
Ask (Size)
11.27 (400)
Prev. Close
10.54
Today's Range
10.99 - 11.48
52wk Range
6.280 - 20.00
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
The Radiopharmaceutical Renaissance: A Deep Dive into Telix Pharmaceuticals (TLX)
Today 9:36 EDT
As of April 13, 2026, Telix Pharmaceuticals Limited (ASX: TLX; NASDAQ: TLX) stands as a pivotal player in the rapidly evolving field of radiopharmaceuticals—a sector that has transformed from a niche...
Via
Finterra
Topics
Economy
Initial Public Offering
Telix and Regeneron Announce Strategic Radiopharma Collaboration
Today 6:30 EDT
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
Performance
YTD
+47.9%
+47.9%
1 Month
+43.6%
+43.6%
3 Month
+49.3%
+49.3%
6 Month
+18.1%
+18.1%
1 Year
-33.1%
-33.1%
More News
Read More
Regeneron and Telix Announce Strategic Radiopharma Collaboration
Today 6:30 EDT
From
Regeneron Pharmaceuticals, Inc.
Via
GlobeNewswire
FDA Accepts NDA for TLX101-Px (Pixclara®)
April 09, 2026
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
Telix Strengthens Board with Additional Director Appointments
April 08, 2026
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
Q1 2026: Strong Revenue Growth and Therapeutics Pipeline Advancement
April 06, 2026
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
Telix Appoints David Gill as Non-Executive Director
April 01, 2026
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
Telix Resubmits NDA to U.S. FDA for TLX101-Px (Pixclara®) Brain Cancer Imaging Candidate
March 15, 2026
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
ProstACT Global Phase 3 Study (Part 1) Achieves Primary Objectives
March 09, 2026
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
Investor Education Webinar
March 01, 2026
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
Telix Joins Forces with University Hospital Essen on PROMISE-PET: Optimizing Patient Management through AI-enabled PSMA-PET Imaging
February 27, 2026
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
1 Basically Unknown Stock That Could Turn Cancer‑Imaging Breakthroughs Into Generational Wealth
↗
February 26, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
Telix to Participate in Oppenheimer and TD Cowen Conferences
February 20, 2026
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
FY 2025 Results: Strong Commercial Growth, Focused Pipeline Investment
February 19, 2026
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
Telix Submits European Marketing Authorization Application for TLX101-Px for Brain Cancer Imaging
February 17, 2026
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
Telix Full Year Results 2025 Investor Webcast Notification
February 03, 2026
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
Telix Achieves FY 2025 Guidance with US$804M (A$1.2B) Revenue, Accelerates Growth with Gozellix Launch
January 20, 2026
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
First U.S. Patient Dosed in BiPASS: Phase 3 Prostate Cancer Diagnosis Study
January 16, 2026
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
TELIX FINAL CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. Urgently Reminds Telix Pharmaceuticals Limited Stockholders to Contact the Firm Regarding Their Rights
January 09, 2026
From
Bragar Eagel & Squire
Via
GlobeNewswire
FINAL DEADLINE ALERT: Faruqi & Faruqi Reminds Telix Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 9, 2026
January 09, 2026
From
Faruqi & Faruqi, LLP
Via
Business Wire
TLX Deadline Tomorrow: Rosen Law Firm Encourages Telix Pharmaceuticals Ltd. Investors to Secure Counsel Before Important January 9 Deadline in Securities Class Action First Filed by the Firm – TLX
January 08, 2026
From
The Rosen Law Firm, P.A.
Via
Business Wire
UPCOMING DEADLINE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Telix Pharmaceuticals
January 08, 2026
From
Faruqi & Faruqi LLP
Via
GlobeNewswire
Deadline Soon: Telix Pharmaceuticals Limited (TLX) Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit
January 08, 2026
From
The Law Offices of Frank R. Cruz
Via
Business Wire
TLX Investors Have Opportunity to Lead Telix Pharmaceuticals Limited Securities Fraud Lawsuit with the Schall Law Firm
January 08, 2026
From
Schall Law
Via
GlobeNewswire
Telix to Present Pipeline and Commercial Portfolio Overview at J.P. Morgan Healthcare Conference
January 08, 2026
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
Frequently Asked Questions
Is Telix Pharmaceuticals Limited - American Depositary Shares publicly traded?
Yes, Telix Pharmaceuticals Limited - American Depositary Shares is publicly traded.
What exchange does Telix Pharmaceuticals Limited - American Depositary Shares trade on?
Telix Pharmaceuticals Limited - American Depositary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Telix Pharmaceuticals Limited - American Depositary Shares?
The ticker symbol for Telix Pharmaceuticals Limited - American Depositary Shares is TLX on the Nasdaq Stock Market
What is the current price of Telix Pharmaceuticals Limited - American Depositary Shares?
The current price of Telix Pharmaceuticals Limited - American Depositary Shares is 11.27
When was Telix Pharmaceuticals Limited - American Depositary Shares last traded?
The last trade of Telix Pharmaceuticals Limited - American Depositary Shares was at 04/13/26 03:27 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
